Home › Atherosclerosis › Connecticut
Atherosclerosis clinical trials in Connecticut
5 studies for Atherosclerosis are looking for participants at sites in Connecticut.
Cities in Connecticut
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
- Yale University School of Medicine Yale-New Haven Hospital (YNHH) - Smilow Cancer Hospital, New Haven
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07448038Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- Cardiology Associates of Fairfield County, P.C., Stamford
- Chase Medical Research, LLC, Waterbury
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07157774Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Greater Hartford Nephrology, LLC, Bloomfield
- Nephrology and Hypertension Associates PC, Middlebury
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Waterbury
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT07000357Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT, West Haven
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Dec 17, 2025 · NCT02915198From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.